Analysts think CRBP stock price could increase by 956%
Apr 06, 2025, 11:25 AM
46.80%
What does CRBP do
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
11 analysts think CRBP stock price will increase by 956.24%. The current median analyst target is $52.02 compared to a current stock price of $4.92. The lowest analysts target is $35.35 and the highest analyst target is $76.65.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
